Monte Rosa Therapeutics, Inc.

GLUE · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $1.5B · 150 employees
80
SEC Filings
$17.74
Close 2026-06-02
150
Employees

Business Summary

1 Item 1A. Risk Factors 85 Item 1B. Unresolved Staff Comments 141 Item 1C. Cybersecurity 141 Item 2. Properties 141 Item 3. Legal Proceedings 142 Item 4. Mine Safety Disclosures 142 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 143 Item 6. [Reserved] 144 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 145 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 15...

Latest Stock Quote

GLUE 2026-06-02 $17.74 O:$19.27 H:$19.375 L:$17.676 Vol:1.0M VWAP:$18.3037
origin leaf: 5ce2995564853cb12a34988d63a35063f2bfa0954e0bceaa8eff3dae6472dcea

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001193125-26-109360EDGAR119K words
2025-03-202024-12-310000950170-25-042344EDGAR—
2024-03-142023-12-310000950170-24-031150EDGAR—
2023-03-162022-12-310000950170-23-008440EDGAR—
2022-03-292021-12-310000950170-22-004927EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268045EDGAR26K words
2025-08-072025-06-300000950170-25-104550EDGAR—
2025-05-082025-03-310000950170-25-066372EDGAR—
2024-11-072024-09-300000950170-24-122780EDGAR—
2024-08-082024-06-300000950170-24-093296EDGAR—
2024-05-092024-03-310000950170-24-056288EDGAR—
2023-11-092023-09-300000950170-23-061995EDGAR—
2023-08-102023-06-300000950170-23-040959EDGAR—
2023-05-112023-03-310000950170-23-021201EDGAR—
2022-11-102022-09-300000950170-22-024447EDGAR—
2022-08-112022-06-300000950170-22-016844EDGAR—
2022-05-112022-03-310000950170-22-009324EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-170001193125-26-109353EDGAR5K words
2026-02-100001193125-26-044616EDGAR—
2026-01-090001193125-26-009005EDGAR—
2026-01-070001193125-26-006341EDGAR—
2026-01-070001193125-26-005420EDGAR—
2025-12-160001193125-25-319981EDGAR—
2025-11-060001193125-25-268042EDGAR—
2025-09-150001193125-25-202760EDGAR—
2025-08-070000950170-25-104545EDGAR—
2025-06-130000950170-25-086129EDGAR—

80 total filings indexed. 53 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001826457
TickerGLUE
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.monterosatx.com
Listed2021-06-24

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: db4ff963ac7929afd264ecc50a328e6f5c5e3a29dc8af1cf1ddd7d0c426c0f34
parent: dc6118ddddb5a5a38ef1eb99fec3256bd2ed025aab68786bc2299cff60d2b2fb
content hash: eee6d3811475708dfe212630298a437cdc6aa8ad31e803c527e8ec23579b8088
signed: 2026-06-03T12:01:16.004Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf